Oppenheimer & CO Inc Moderna, Inc. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 37,787 shares of MRNA stock, worth $1.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

37,787

Previous 42,931 11.98%

Holding current value

$1.39 Million

Previous $5.1 Million 50.47%

% of portfolio

0.04%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$63.64 - $125.14 $327,364 - $643,720	-5,144 Reduced 11.98%	37,787 $2.53 Million
Q2 2024 Aug 07, 2024	BUY	$101.21 - $166.61 $265,777 - $437,517	2,626 Added 6.52%	42,931 $5.1 Million
Q1 2024 May 06, 2024	BUY	$85.37 - $115.44 $701,229 - $948,224	8,214 Added 25.6%	40,305 $4.29 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $876,590 - $1.32 Million	-12,611 Reduced 28.21%	32,091 $3.19 Million
Q3 2023 Nov 07, 2023	BUY	$96.41 - $126.61 $74,139 - $97,363	769 Added 1.75%	44,702 $4.62 Million
Q2 2023 Aug 02, 2023	SELL	$118.5 - $160.53 $327,771 - $444,025	-2,766 Reduced 5.92%	43,933 $5.34 Million
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $217,869 - $316,414	1,606 Added 3.56%	46,699 $7.17 Million
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $472,217 - $837,849	-3,989 Reduced 8.13%	45,093 $8.1 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $432,490 - $711,281	-3,663 Reduced 6.94%	49,082 $5.8 Million
Q2 2022 Aug 08, 2022	SELL	$117.13 - $176.59 $1.68 Million - $2.54 Million	-14,369 Reduced 21.41%	52,745 $7.53 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $925,181 - $1.72 Million	7,316 Added 12.23%	67,114 $11.6 Million
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $2.03 Million - $3.3 Million	-8,968 Reduced 13.04%	59,798 $15.2 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $4.78 Million - $10.4 Million	-21,558 Reduced 23.87%	68,766 $26.5 Million
Q2 2021 Aug 03, 2021	SELL	$129.91 - $234.98 $1.1 Million - $1.99 Million	-8,470 Reduced 8.57%	90,324 $21.2 Million
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $2.79 Million - $4.75 Million	25,539 Added 34.86%	98,794 $12.9 Million
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $6,113 - $15,796	-93 Reduced 0.13%	73,255 $7.65 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $233,553 - $407,665	4,298 Added 6.22%	73,348 $5.19 Million
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $876,985 - $2.36 Million	29,558 Added 74.85%	69,050 $4.43 Million
Q1 2020 May 08, 2020	BUY	$17.78 - $31.58 $702,167 - $1.25 Million	39,492 New	39,492 $1.18 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Moderna, Inc. Transaction History